 ENGLEWOOD, Colo., Aug. 11, 2021 PRNewswire -- Ampio Pharmaceuticals, Inc. NYSE American: AMPE, a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions for which there are limited treatment options, today announced that the company will host one-on-one investor meetings at the following investor conferences: H.C. 